Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice
In response to the human Mpox (hMPX) epidemic that began in 2022, there is an urgent
need for a monkeypox vaccine. Here, we have developed a series of mRNA-lipid …
need for a monkeypox vaccine. Here, we have developed a series of mRNA-lipid …
Opto-microfluidic assisted synthesis of photo-protoporphyrin (pPP) conjugated to hollow gold-albumin hybrid nanoshells to enhance the efficiency of photodynamic …
Abstract Introduction Protoporphyrin-IX (PpIX), a photosensitizer used in photodynamic
therapy, has limitations due to its hydrophobicity, rapid photobleaching, and low absorption …
therapy, has limitations due to its hydrophobicity, rapid photobleaching, and low absorption …
Design and immunogenicity of SARS-coV-2 DNA vaccine encoding RBD-PVXCP fusion protein
D Dormeshkin, M Katsin, M Stegantseva… - Vaccines, 2023 - mdpi.com
The potential of immune-evasive mutation accumulation in the SARS-CoV-2 virus has led to
its rapid spread, causing over 600 million confirmed cases and more than 6.5 million …
its rapid spread, causing over 600 million confirmed cases and more than 6.5 million …
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized …
M Salehi, IA Darazam, A Nematollahi… - International …, 2024 - Elsevier
The recurrent COVID-19 infection, despite global vaccination, highlights the need for booster
doses. A heterologous booster has been suggested to enhance immunity and protection …
doses. A heterologous booster has been suggested to enhance immunity and protection …
Novel synthesized ionizable lipid for LNP-mediated P2X7siRNA to inhibit migration and induce apoptosis of breast cancer cells
The development of ionizable lipid (IL) was necessary to enable the effective formulation of
small interfering RNA (siRNA) to inhibit P2X7 receptors (P2X7R), a key player in tumor …
small interfering RNA (siRNA) to inhibit P2X7 receptors (P2X7R), a key player in tumor …
Safety and immunogenicity of COReNAPCIN®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial
M Salehi, IA Darazam, A Nematollahi… - medRxiv, 2023 - medrxiv.org
The repeated COVID-19 outbreaks, despite global vaccination, highlights the need for
booster doses. Here, we present the outcomes, up until day 90 post vaccination, of a …
booster doses. Here, we present the outcomes, up until day 90 post vaccination, of a …
Produção de Antígeno Multiepítopo Sintético do SARS-CoV-2 em Sistema de Expressão Bacteriano
MATM Gama - 2022 - repositorio.ufpe.br
Atualmente, o processo de imunização da população mundial contra o SARS-CoV-2,
responsável pelo quadro pandêmico mais impactante para a saúde pública dos últimos …
responsável pelo quadro pandêmico mais impactante para a saúde pública dos últimos …